nj acts logo

We invite abstracts from the Rutgers, Princeton, and NJIT research communities. Abstracts will be reviewed by the session co-chairs and two abstracts will be selected for presentations and others for the poster session.  In addition, there is a special category for NJ ACTS Pilot Awardees, KL2 Scholars, and TL1 Trainees.

NEW Deadline for Abstracts:  August 26 at midnight, using the on-line form.

This Symposium brings together the NJ ACTS academic communities of Rutgers, Princeton and NJIT to present the best new clinical and translational research and build collaborative partnerships. The two-day conference will feature sessions on four hot topics with internal talks chosen from the abstracts and an external international keynote speakers:


  • Inclusion, Diversity and Equity in AI and Machine Learning

Keynote by Fei Wang, PhD, Associate Professor of Healthcare Policy and Research Weill Cornell Medicine and Associate Professor of Population Health Sciences

  • Social and Environmental Determinants of Health in the Urban Setting

Keynote by Olajide Williams, MD, Professor of Neurology; Chief of Staff of Neurology; Associate Dean of Community Research and Engagement, New York-Presbyterian Columbia University Irving Medical Center

  • Clinical Trial Science after a Pandemic

Keynote by Dean Fergossen, MHA, PhD, Professor, De- partments of Medicine, Surgery, & the School of Epidemiology and Public Health, University of Ottawa

  • Biomarker Exploration in the Heterogeneity of Disease

Keynote by Eran Elinav, M.D. Ph.D., Principal Investigator, Host-Microbiome Interaction Research Group, Weizmann Institute of Science, Israel and HHMI & the Bill and Melinda Gates Foundation International Research Scholar